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Study Valls-Pedret, et al C. Feart, et al R. Roberts, et al N. Scarmeas, et al
Patients, N 447 1410 2719 2258
Type of Study RCT Prospective cohort Cross-sectional Prospective cohort 
Population Males and Females 
55-80 years at high 
risk of CVD
Males and Females 
>65 at high risk of 
dementia 
Males and Females 70-
89 years
Males and Females 
enrolled in Medicaid in NY, 
USA. Mean age 77.6
Length 6 years (mean 4.1) 7 years N/A 0.2-19.19 years 
Study Objective Investigate whether 
MeDi supplemented 
with antioxidant-rich 
foods influences 
cognitive function 
compared with a 
control diet
Association of MeDi
with change in 
cognitive 
performance and risk 
for dementia in 
individuals over the 
age of 65. 
To investigate 
associates of the MeDi
diet components and 
the MeDi score 
associated with Mild 
Cognitive Impairment 
(MCI). 
Investigate an association 
between the MeDi and 
decreased risk of 
Alzheimer Disease 
Study Results MeDi with olive oil or 
nut supplementation 
resulted in decreased 
cognitive decline.
Higher MeDi
adherence correlated 
with slower MMSE 
cognitive decline.
Higher MeDi adherence 
was associated with 
decreased odds ratio of 
MCI and amnestic-MCI.
High adherence to MeDi
correlated with a 40% 
decreased risk of 
developing AD. 
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Abstract
Objective: Determine if a significant clinical correlation exists between adherence to a
Mediterranean Diet and decreased lifetime risk of Alzheimer disease in non-demented adults 60-80
years old.
Design: Systematic literature review.
Methods: Searches were done in PubMed using MESH terms cognitive decline, low fat diet,
Mediterranean, and prevention; in PubMed the following limits and terms were applied: published in
the last 12 years, humans, English; excluding meta-analyses and systematic reviews.
Results: The systematic review yielded four studies: a randomized control trial completed by C.
Valls-Pedret et al. (2015), two prospective cohort studies by C. Feart et al. (2009) and N. Scarmeas et
al. (2006), and a cross-sectional observational study by R. Roberts et al. (2010).
Conclusion: The studies evaluated by this paper find a significant correlation between a high-
adherence to the entire Mediterranean Diet and decreased incidence of Alzheimer Disease and
cognitive decline, though further research is recommended.
Introduction
Alzheimer disease is the sixth leading cause of death in the United States, and is the third
leading cause of death in the U.S. elderly population.1 It is the most common form of dementia, and
is a progressive irreversible disease with high economical and psychological. Alzheimer disease is
thought to be caused by pathological deposits of amyloid beta plaques and neurofibrillary tangles in
the cerebral cortex, hippocampus, and amygdala.2 The neurological changes lead to clinical
presentations of declarative episodic memory loss, deficits in executive functioning, and behavioral
changes.3 Due to the incidence, high mortality and morbidity, and absence of cure of Alzheimer
disease, a clinical focus must be made on prevention.
Recent studies have focused on the use of the Mediterranean Diet (MeDi) and a correlated
decreased lifetime risk of developing Alzheimer disease and other age-related dementias. The MeDi
diet incorporates high consumption of foods such as olive oil, vegetables, fruits, legumes, nuts, fish
and seafood, moderate consumption of red wine, dairy, eggs, and poultry, and minimizes consumption
of red meat and sugar.4 This diet has been correlated with improvements of cardiovascular health
and malignancy prevention, however impact on cognitive decline has not yet been proven. This
study analyzes one randomized control trial, two prospective cohort studies, and one cross-sectional
observational study—aiming to determine if a significant clinical correlation exists between
adherence to a MeDi diet and decreased lifetime risk of Alzheimer disease of adults ages 60-80
years of age.
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Additional records identified through other 
sources 
Google Scholar “Alzheimer Disease, low fat diet, 
prevention” 
(n = 41) 
Records after duplicates removed 
(n =  77) 
Records screened 
Inclusion factors: Human only, adults, English, within 10 
years, RCTs, observational studies 
(n = 77) 
Records excluded by reading 
titles/abstracts: 
Non-human study, >15 years, 
systematic reviews, meta-
analyses, insufficient 
conclusions (n =  69 ) 
Full-text articles assessed 
for eligibility 
(n = 8) 
Full-text articles excluded 
due to insufficient 
conclusions, multifactorial 
broad questions 
(n =4 ) 
Studies included in 
qualitative synthesis 
(n =  4 ) 
Studies included in quantitative synthesis (meta-analysis) 
(n = 4) 
 
1. Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial. 2015  
2. Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia 
3. Vegetables, Unsaturated Fats, Moderate Alcohol Intake, and Mild Cognitive Impairment, R. Roberts, et al. (2010) 
4. Mediterranean Diet and Risk for Alzheimer’s Disease, N. Scarmeas, et al. (2006) 
 
 
Methods
• Study #1 Critique:
• Strengths: RCT, the use of objective biomarkers, the use of comprehensive battery
exams to determine cognitive functions
• Limitations: Small sample size, hard to interpret what part of the diet impacted
cognition.
• Study #2 Critique:
• Strengths: population-based design, the sample size, and control for several
potential cofounders like the including and excluding criteria
• Limitations: Non-diverse population, the use of sex-specific cutoff points, short
follow up, no definite association amongst Medi diet and incidental dementia
• Study #3 Critique:
• Strengths: Randomly selected sample, multi-person clinical evaluation,
preliminary longitudinal associations
• Limitations: Cross-sectional design, recall bias
• Study #4 Critique:
• Strengths: Thorough and blinded clinical evaluation, multiple stratifications of
data analysis, multiethnic community population
• Limitations: Did not stratify cardiovascular risk factors as confounders, possible
recall bias, unclear lifetime risk reduction due to short follow-up
Survival curves from Cox analysis comparing cumulative 
AD incidence in subjects in each MeDi tertile group. 
Corresponding to low, middle, or high diet adherence.8
• The four study objectives are very similar, using cognitive evaluations by neurologists and neuropsychologists to
evaluate a correlation between the Mediterranean Diet and prevention of cognitive decline.
• The outcomes of the studies are supported by each other, with an overwhelming conclusion that a higher adherence to
the entire MeDi correlates with a reduced risk of AD incidence and MCI in followed subjects.
• The smallest study, Valls-Pedret, is weak in its sample size but is also the only randomized control trial on the topic of
AD and MeDi, which gives it more causality strength in its conclusion.
• Due to study type and design, the studies done by C. Feat, R. Roberts, and N. Scarmeas can only make significant
correlations rather than causation.
• The implementation and evaluation of MeDi is very difficult to maintain, especially with the food questionnaires used
by C. Feat, R. Roberts, and N. Scarmeas and the likely presence of recall bias.
• Possible limitations:
• Time-consuming MeDi meal preparation and economic cost
• Practical and realistic problem with elderly patients who may not be solely responsible for preparing his or her
own meals
• The moderate intake of red wine may pose a problem for those with a history of alcoholism, liver disease, or a
religious or personal beliefs prohibiting alcohol consumption
• Uncertain benefits with earlier implementation of diet before the age of 60
• A high-adherence to the MeDi diet should be recommended and considered in adults over the age of 55.
• Further investigation be made on this topic to include a larger population size, more diverse age groups, and
randomized control trials.
Discussion
The results of this study suggest that in an older population a high adherence to
the Mediterranean diet may protect against Alzheimer Disease and other age-related
cognitive decline. Although current research lacks causative evidence of how immensely
the MeDi benefits individuals, the positive aspects of our findings cannot be ignored
because of the lack of cure of neurodegenerative disease.
The lack of effective treatments for cognitive decline and dementia point to the
need of preventive strategies to delay the onset and minimize the effects of these
devastating conditions. It is unclear which parts of the diet may protect cognitive function,
or how strong the correlation is between diet and decreasing incidence of lifetime risk of
neurodegenerative disease; however, the recent findings convey some likelihood of the
disease reduction process. The present results of implementing a Mediterranean diet are
strongly encouraging, but further investigation is warranted.
Conclusion
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